返回
李永胜 (Yongsheng Li)
Xinjiang Medical University
74H指数
495论文数
2.0W被引数
收录论文 276
发表时间
Glecirasib with or without cetuximab in previously treated locally advanced or metastatic colorectal cancer with KRASG12C mutation (JAB-21822-1002 and JAB-21822-1007): two open-label, non-randomised phase 1/2 trialsGlecirasib联合或不联合西妥昔单抗治疗既往经治的局部晚期或转移性KRASG12C突变结直肠癌(JAB-21822-1002和JAB-21822-1007):两项开放标签、非随机化I/II期临床试验

